Viewing Study NCT00003395


Ignite Creation Date: 2025-12-24 @ 2:19 PM
Ignite Modification Date: 2026-02-02 @ 1:52 AM
Study NCT ID: NCT00003395
Status: COMPLETED
Last Update Posted: 2013-06-25
First Post: 1999-11-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
None Lymphoma View
None Multiple Myeloma and Plasma Cell Neoplasm View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage IV adult Hodgkin lymphoma View
None recurrent adult Hodgkin lymphoma View
None stage IV cutaneous T-cell non-Hodgkin lymphoma View
None recurrent cutaneous T-cell non-Hodgkin lymphoma View
None refractory multiple myeloma View
None Waldenström macroglobulinemia View
None stage III multiple myeloma View
None stage IV chronic lymphocytic leukemia View
None recurrent adult acute myeloid leukemia View
None recurrent adult acute lymphoblastic leukemia View
None relapsing chronic myelogenous leukemia View
None refractory chronic lymphocytic leukemia View
None chronic phase chronic myelogenous leukemia View
None accelerated phase chronic myelogenous leukemia View
None blastic phase chronic myelogenous leukemia View
None meningeal chronic myelogenous leukemia View
None adult acute erythroid leukemia (M6) View
None adult acute myeloblastic leukemia without maturation (M1) View
None adult acute myeloblastic leukemia with maturation (M2) View
None adult acute myelomonocytic leukemia (M4) View
None adult acute monoblastic leukemia (M5a) View
None adult acute eosinophilic leukemia View
None adult acute basophilic leukemia View
None adult acute megakaryoblastic leukemia (M7) View
None progressive hairy cell leukemia, initial treatment View
None refractory hairy cell leukemia View
None acute undifferentiated leukemia View
None stage IV grade 1 follicular lymphoma View
None stage IV grade 2 follicular lymphoma View
None stage IV grade 3 follicular lymphoma View
None stage IV adult diffuse small cleaved cell lymphoma View
None stage IV adult diffuse mixed cell lymphoma View
None stage IV adult diffuse large cell lymphoma View
None stage IV adult immunoblastic large cell lymphoma View
None stage IV adult lymphoblastic lymphoma View
None stage IV adult Burkitt lymphoma View
None recurrent grade 1 follicular lymphoma View
None recurrent grade 2 follicular lymphoma View
None recurrent grade 3 follicular lymphoma View
None recurrent adult diffuse small cleaved cell lymphoma View
None recurrent adult diffuse mixed cell lymphoma View
None recurrent adult diffuse large cell lymphoma View
None recurrent adult immunoblastic large cell lymphoma View
None recurrent adult lymphoblastic lymphoma View
None recurrent adult Burkitt lymphoma View
None stage IV adult T-cell leukemia/lymphoma View
None recurrent adult T-cell leukemia/lymphoma View
None secondary acute myeloid leukemia View
None adult acute monocytic leukemia (M5b) View
None primary central nervous system non-Hodgkin lymphoma View
None AIDS-related peripheral/systemic lymphoma View
None AIDS-related primary CNS lymphoma View
None adult acute minimally differentiated myeloid leukemia (M0) View
None intraocular lymphoma View
None stage IV mantle cell lymphoma View
None recurrent mantle cell lymphoma View
None anaplastic large cell lymphoma View
None stage IV mycosis fungoides/Sezary syndrome View
None recurrent mycosis fungoides/Sezary syndrome View
None juvenile myelomonocytic leukemia View
None recurrent marginal zone lymphoma View
None recurrent small lymphocytic lymphoma View
None stage IV small lymphocytic lymphoma View
None stage IV marginal zone lymphoma View
None extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue View
None nodal marginal zone B-cell lymphoma View
None splenic marginal zone lymphoma View